Table 1 –

Baseline LLT recipient and donor characteristics between the historic (pre-LAS) and modern (post-LAS) cohorts.

Characteristic	Historic (pre-LAS)	Modern (post-LAS)	P
n	10	52
Age	37.50 (15.28)	37.00 (15.58)	0.926
Male gender	8 (80.0)	31 (59.6)	0.387
White	10 (100.0)	50 (96.2)	0.999
Recipient BMI	20.71 (3.63)	21.54 (4.05)	0.55
Donor age	30.90 (11.12)	29.48 (13.59)	0.757
Donor BMI	22.84 (2.04)	23.32 (3.97)	0.713
Previous transplant	0.00 (0.00)	0.02 (0.14)	0.665
Diabetes	2 (20.0)	23 (44.2)	0.281
FEV1%	48.22 (31.82)	29.82 (17.42)	0.014
Total bilirubin	1.58 (1.35)	2.38 (6.46)	0.699
Serum albumin at transplant	3.55 (0.13)	3.25 (0.62)	0.34
Creatinine at transplant	1.22 (0.70)	0.72 (0.31)	<0.001
MELD-XI	14.30 (5.77)	11.48 (4.01)	0.064
Lung diagnosis			0.003
Cystic fibrosis	5 (50.0)	30 (57.7)
Primary pulmonary hypertension	4 (40.0)	0 (0.0)
Secondary pulmonary hypertension	0 (0.0)	2 (3.8)
Idiopathic pulmonary fibrosis	0 (0.0)	9 (17.3)
Pulmonary fibrosis—other	1 (10.0)	3 (5.8)
Alpha-1-antitrypsin deficiency	0 (0.0)	3 (5.8)
COPD/emphysema	0 (0.0)	1 (1.9)
Sarcoidosis	0 (0.0)	1 (1.9)
Other	0 (0.0)	2 (3.8)
Liver diagnosis			0.10
Cystic fibrosis	5	30
Alpha-1-antitrypsin	0	3
Alcoholic cirrhosis	2	2
Biliary cirrhosis	0	1
Cirrhosis (other)	2	12
Non–nonalcoholic steatohepatitis	0	1
Hepatocellular carcinoma (HCC)	0	1
Other	1	2

Categorical data are reported as n (%), and continuous data are reported as mean (SD) unless otherwise stated.